Standard
Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial. / Astrup, Arne; van Gaal, Luc; Rissanen, Aila; Niskanen, Leo; Al Hakim, Mazin; Madsen, Jesper; Rasmussen, Mads Frederik; Rössner, Stephan.
In:
Obesity, Vol. 16, No. suppl 1, 2008, p. S64.
Research output: Contribution to journal › Conference abstract in journal › Research
Harvard
Astrup, A, van Gaal, L, Rissanen, A, Niskanen, L, Al Hakim, M, Madsen, J, Rasmussen, MF & Rössner, S 2008, 'Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial', Obesity, vol. 16, no. suppl 1, pp. S64.
APA
Astrup, A., van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Rössner, S. (2008). Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial. Obesity, 16(suppl 1), S64.
Vancouver
Astrup A, van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J et al. Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial. Obesity. 2008;16(suppl 1):S64.
Author
Astrup, Arne ; van Gaal, Luc ; Rissanen, Aila ; Niskanen, Leo ; Al Hakim, Mazin ; Madsen, Jesper ; Rasmussen, Mads Frederik ; Rössner, Stephan. / Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial. In: Obesity. 2008 ; Vol. 16, No. suppl 1. pp. S64.
Bibtex
@article{5a06c79001ac11deb05e000ea68e967b,
title = "Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial",
author = "Arne Astrup and {van Gaal}, Luc and Aila Rissanen and Leo Niskanen and {Al Hakim}, Mazin and Jesper Madsen and Rasmussen, {Mads Frederik} and Stephan R{\"o}ssner",
note = "Udgivelsesdato: October 2008 Volumne: 16; null ; Conference date: 03-10-2008 Through 07-10-2008",
year = "2008",
language = "English",
volume = "16",
pages = "S64",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "suppl 1",
}
RIS
TY - ABST
T1 - Liraglutide, a once-daily human GLP-1 analogue, reduces body weight and improves obesity-related risk factors in obese non-diabetic subjects: A randomised placebo-controlled trial
AU - Astrup, Arne
AU - van Gaal, Luc
AU - Rissanen, Aila
AU - Niskanen, Leo
AU - Al Hakim, Mazin
AU - Madsen, Jesper
AU - Rasmussen, Mads Frederik
AU - Rössner, Stephan
N1 - Udgivelsesdato: October 2008
Volumne: 16
PY - 2008
Y1 - 2008
M3 - Conference abstract in journal
VL - 16
SP - S64
JO - Obesity
JF - Obesity
SN - 1930-7381
IS - suppl 1
Y2 - 3 October 2008 through 7 October 2008
ER -
